Construction and expression of eukaryotic expression vector of human SYNOVIOLIN gene
Zheng‐Zhi Zhang
Abstract
Zheng‐Zhi Zhang
Abstract
Objective:To construct eukaryotic expression vector containing the EGFP-SYNOVIOLIN gene.Methods:According to the sequence of SYNOVIOLIN gene and the multiple clone sites of the expression vector pIRES2-EGFP plasmid,a specific pair of primers were designed and synthesize.PCR amplification of SYNOVIOLIN gene from the pCDNA3-syno plasmid was performed,and an approximate 1900bp objective fragment was achieved.The fragment was then cloned into T-A vector.The recombined vector confirmed by sequencing was digested by SalⅠ/BamHⅠ to obtain SYNOVIOLIN cDNA fragment,then the fragment was subcloned into the multiple sites of pIRES2-EGFP vector.The recombinant plasmid pIRES2-EGFP-syno was transfected into HEK293 cell by lipofectamine 2000.The result was examined using confocal microscopy.The expression of SYNOVIOLIN was detected by Western blotting.Results:PCR,DNA sequencing and restriction enzyme digestion analysis indicated that the eukaryotic expression vector pIRES2-EGFP-syno was constructed successfully.The expression of EGFP can be seen under confocal microscopy.Western blotting proved the protein expression of SYNOVIOLIN in HEK 293 cells.Conclusions:The SYNOVIOLIN cDNA is acquired and the eukaryotic expression vector,pIRES2-EGFP-syno is successfully constructed with efficient expression in HEK293 cells,which provide a good experimental basis for further study on the gene therapy of anti-tendon adhesion.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To construct eukaryotic expression vector containing the EGFP-SYNOVIOLIN gene.Methods:According to the sequence of SYNOVIOLIN gene and the multiple clone sites of the expression vector pIRES2-EGFP plasmid,a specific pair of primers were designed and synthesize.PCR amplification of SYNOVIOLIN gene from the pCDNA3-syno plasmid was performed,and an approximate 1900bp objective fragment was achieved.The fragment was then cloned into T-A vector.The recombined vector confirmed by sequencing was digested by SalⅠ/BamHⅠ to obtain SYNOVIOLIN cDNA fragment,then the fragment was subcloned into the multiple sites of pIRES2-EGFP vector.The recombinant plasmid pIRES2-EGFP-syno was transfected into HEK293 cell by lipofectamine 2000.The result was examined using confocal microscopy.The expression of SYNOVIOLIN was detected by Western blotting.Results:PCR,DNA sequencing and restriction enzyme digestion analysis indicated that the eukaryotic expression vector pIRES2-EGFP-syno was constructed successfully.The expression of EGFP can be seen under confocal microscopy.Western blotting proved the protein expression of SYNOVIOLIN in HEK 293 cells.Conclusions:The SYNOVIOLIN cDNA is acquired and the eukaryotic expression vector,pIRES2-EGFP-syno is successfully constructed with efficient expression in HEK293 cells,which provide a good experimental basis for further study on the gene therapy of anti-tendon adhesion.
Key concepts: Molecular biology, Plasmid, Lipofectamine, Complementary DNA, Biology, Expression vector, Transfection, Recombinant DNA